Search - tctmd.com

Displaying 861 - 880 of 2419

Sort: Relevancy | Date

News Industry News

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

February 07, 2017

News Industry News

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

January 30, 2017

News Daily News

Radiation Risks for Radial Operators Can Be Cut With Cheap, Effective Pelvic Drapes

L.A. McKeown

January 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

Believe It: Mitral Valve Repair Beats Replacement for Severe Regurgitation, Registry Shows

Shelley Wood

December 05, 2016

News Industry News

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

December 01, 2016

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Daily News

Intracardiac Shunts After TAVR: Rare but Potentially Lethal

Todd Neale

November 28, 2016

News Industry News

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

November 21, 2016

News Industry News

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

November 03, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

Presentation TCT 2016

TCT 259: Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidence and Outcomes

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

Presentation TCT 2016

TCT 252: The Incidence, Determinants and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 20062013: an analysis of 527,121 Cases from the British Cardiovascular Intervention Society Database

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

Presentation TCT 2016

TCT 251: Non-procedural Predictors of Stroke After Percutaneous Coronary Intervention

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

Presentation TCT 2016

TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

Presentation TCT 2016

TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials.

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

Presenter: Fernando Alfonso, Ran Kornowski, Josep Rodés-Cabau

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

Presentation TCT 2016

Flash Perspectives on Percutaneous Circulatory Support: An IABP Is Really All a Good Interventionalist Needs!

Presenter: Ulrich P. Jorde, William W. O'Neill, Gert Richardt

October 31, 2016

Advertisement

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease

Radiation Risks for Radial Operators Can Be Cut With Cheap, Effective Pelvic Drapes

TCTMD’s Top 10 Most Popular News and Features for 2016

Believe It: Mitral Valve Repair Beats Replacement for Severe Regurgitation, Registry Shows

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

Intracardiac Shunts After TAVR: Rare but Potentially Lethal

Two Differing Blood Clot Prevention Medications Used During Heart Procedure Are Both Safe and Effective for Patients, New Study Finds

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

TCT 259: Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidence and Outcomes

TCT 252: The Incidence, Determinants and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 20062013: an analysis of 527,121 Cases from the British Cardiovascular Intervention Society Database

TCT 251: Non-procedural Predictors of Stroke After Percutaneous Coronary Intervention

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

TCT 412: Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry

TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials.

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

Flash Perspectives on Percutaneous Circulatory Support: An IABP Is Really All a Good Interventionalist Needs!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content